Synopsys Secures $1B Amazon Deal, Partners With OpenAI, and Launches $1B Share Buyback
Synopsys, Inc. (NASDAQ:SNPS) has entered into a multi-part expansion strategy featuring a licensing agreement worth more than $1 billion with Amazon, an artificial intelligence collaboration with OpenAI, and a $1 billion share repurchase program. Following these developments, Synopsys stock advanced 2.46% to $510.
The contract with Amazon grants a license for Synopsys intellectual property across Graviton, Trainium, and Nitro processors, alongside customization fees and projected long-term royalty revenue. In tandem, Synopsys is collaborating with OpenAI to build GPT-Synopsys, an AI agent aimed at automating chip design software, expanding the design space, and shortening time-to-market. Analysts at Needham kept a Buy rating and a $620 price target on the company, citing higher earnings projections and expanding royalty potential.
Looking ahead, investors will keep an eye on the execution of the $1 billion accelerated share repurchase handled by JPMorgan. Synopsys received roughly 1,735,000 shares upfront, with the final repurchase count determined by volume-weighted average prices through January 5, 2027.
Key points
- Synopsys signed a $1B-plus IP licensing deal with Amazon covering Graviton, Trainium, and Nitro chips along with royalties.
- Synopsys and OpenAI are building GPT-Synopsys, an AI agent designed to automate electronic design automation workflows.
- The company launched a $1B accelerated share buyback with JPMorgan, receiving about 1,735,000 shares upfront.
- Needham maintained a Buy rating on Synopsys stock with a price target of $620 based on higher earnings estimates.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What is the details of the Synopsys and Amazon agreement?
Synopsys signed a $1B-plus licensing deal to provide its IP across Amazon Graviton, Trainium, and Nitro chips, while also collecting customization fees and long-term royalties.
What is GPT-Synopsys and how does it work with OpenAI?
GPT-Synopsys is an AI agent built with OpenAI to run electronic design automation tools, accelerating chip design workflows and shortening time-to-market.
How many shares is Synopsys buying back in its repurchase program?
Synopsys launched a $1B accelerated repurchase with JPMorgan, receiving about 1,735,000 shares upfront with final counts determined by VWAP through Jan 5, 2027.